(Q51031039)

27 March 2018

title

Heart rate variability in patients with systemic lupus erythematosus. (English)

1 reference

27 March 2018

systemic lupus erythematosus

main subject

heart rate variability

0 references

0 references

4

Ginzler EM

1 reference

27 March 2018

author name string

Stein KS

series ordinal

1

1 reference

27 March 2018

McFarlane IC

series ordinal

2

1 reference

27 March 2018

Goldberg N

series ordinal

3

1 reference

27 March 2018

publication date

1 February 1996

1 reference

27 March 2018

published in

Lupus

1 reference

27 March 2018

volume

5

1 reference

27 March 2018

issue

1

1 reference

27 March 2018

page(s)

44-48

1 reference

27 March 2018

A controlled study of chloroquine as an antirheumatic agent

cites work

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Chloroquine diphosphate in rheumatoid arthritis. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6-month comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

A single-blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Should disease-modifying agents be used in mild rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

Variations among rheumatologists in prescribing and monitoring of disease modifying antirheumatoid drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339600500109

10.1177/096120339600500109

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018